
May (Mahmood) Alattar MD M.B. Ch, B
Adrenal Disease, Diabetes, Lipid Metabolism, Thyroid
Physician
Join to View Full Profile
3400 Douglas Blvd #170,Roseville, CA 95661
Phone+1 855-446-8628
Fax+1 916-527-0770
Dr. Alattar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- May (Mahmood) Alattar, MD, is an Endocrinologist based in Washington DC. Dr. Alattar's subspecialities include Adrenal Disease, Diabetes, Lipid Metabolism, and Thyroid. She has a rich educational background with a residency in Internal Medicine at MedStar Health/Harbor Hospital, a fellowship in Endocrinology, Diabetes, and Metabolism at the National Institutes of Health Clinical Center, and is a graduate of University of Al-Mustansiriyah College of Medicine. She is currently serving as telemedicine endocrinologist (Telemed2U), Endocrine hospitalist at Johns Hopkins Primary Physicians and has previously served as a faculty physician at the University of Maryland Medical Center. Dr. Alattar also has several publications in Cures, Diabetes Care, Clin. Exp. Immunol, and Endocrine Practice.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011
MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 2006 - 2009
University of Al-Mustansiriyah College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2022 - 2028
DC State Medical License 2019 - 2027
KY State Medical License 2023 - 2027
OR State Medical License 2026 - 2027
MD State Medical License 2009 - 2026
VA State Medical License 2011 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 4 citationsIs Testosterone Replacement Safe in Men with Cardiovascular DiseaseTalha Ahmed, May Alattar, Kevin M. Pantalone, Reyaz Haque
Cureus. 2020-03-19 - Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-10-01 - 63 citationsExenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 DiabetesGayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-03-01
Journal Articles
- Elevated Amylase and Lipase in Patients Using GLP-1 Agonists or DPP-4 Inhibitors in the Outpatient SettingHoward Lando, May Alattar, Endocrine Practice, 8/2012
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









